Q3 2025 Earnings Call Transcript October 29, 2025 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.01, ...

Sarasota Memorial Hospital is among 100 sites testing a new device for long-term medication use for atrial fibrillation ...

Trial will evaluate the safety and effectiveness of the AtriCure Isolator® Synergy™ EnCompass® clamp and AtriClip® Left ...

Michigan Medicine Cardiovascular Center researchers and clinicians are expanding atrial fibrillation treatment options.

Recent findings may be relevant to discussions with patients and their families about the pros and cons of cardiac surgery.

Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It's the ...

St. Helena Hospital’s cardiac surgery team recently performed an experimental heart procedure that was the first of its kind ...

The procedure was carried out by Orlando Health Heart and Vascular Institute cardiothoracic surgeon Dr Anthony Rongione.

As part of Methodist Hospital Texsan’s continued efforts to prevent strokes in South Texas, the hospital announced on Oct. 23 that its Cardiac Electrophysiology, EP, team has successfully performed ...

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy technologies.

UF Health, Ascension St. Vincent's, Florida Eye Specialists and the Florida Medical Association are making the news with new ...